[Impetigo herpetiformis (two cases)]

J Gynecol Obstet Biol Reprod (Paris). 2008 Dec;37(8):804-7. doi: 10.1016/j.jgyn.2008.06.002. Epub 2008 Jul 26.
[Article in French]

Abstract

The hepetiformis impetigo is a pustulosis dermatosis. It is rare and specific to pregnancy. It can menace the prognostic of the mother and the child. This entity is actually considered as a pustulor psoriasis. We report two cases.

Cases reports: Two patients, respectively, aged 24 and 21, presented erythematous, pustular and extensive plaques for which the diagnosis of hepetiformis impetigo was clinically and histologically posed. For the first patient, the lesions appeared in the two pregnancies and were more severe and foetal repercussions (oligoamnios and hypotrophy) during the second pregnancy. For the second patient, the pregnancy was complicated with premature interruption of the membrane, giving birth to a deed fetus and causing an aggravation of the cutaneous lesions. The treatment was oral steroid followed by acitretin for the first patient, however, for the second patient; the treatment was by local steroid associated with UVB during the pregnancy. Then, acitrétine was used and was efficient.

Conclusion: Our two cases show the importance of gynaecological control in order to avoid complications which can be sometimes fatal. They also show the importance of local steroid associated with UVB which constitute another therapeutic alternative in the treatment of hepetiformis impetigo.

Publication types

  • Case Reports
  • English Abstract

MeSH terms

  • Acitretin / therapeutic use*
  • Dermatitis Herpetiformis / complications*
  • Dermatitis Herpetiformis / drug therapy
  • Dermatitis Herpetiformis / pathology
  • Diagnosis, Differential
  • Female
  • Humans
  • Impetigo / complications*
  • Impetigo / drug therapy
  • Impetigo / pathology
  • Infant, Newborn
  • Keratolytic Agents / therapeutic use*
  • Pregnancy
  • Pregnancy Complications, Infectious / drug therapy*
  • Pregnancy Complications, Infectious / pathology
  • Treatment Outcome
  • Young Adult

Substances

  • Keratolytic Agents
  • Acitretin